Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Expenditure

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Expenditure ₹2,512 Cr₹2,572 Cr₹2,545 Cr₹2,447 Cr₹2,516 Cr

What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Expenditure ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹2,512 Cr based on Mar2026 Consolidated results.
Year Total Expenditure
Mar2026₹2,512 Cr
Mar2025₹2,572 Cr
Mar2024₹2,545 Cr
Mar2023₹2,447 Cr
Mar2022₹2,516 Cr

How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Expenditure % Change
Mar2026 ₹2,512 Cr
-2.31
Mar2025 ₹2,572 Cr
1.05
Mar2024 ₹2,545 Cr
3.99
Mar2023 ₹2,447 Cr
-2.73
Mar2022 ₹2,516 Cr -

Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,921.8 Cr 7% 6.7% -4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹113,589.0 Cr 0.4% 7.9% -6.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

7%

6.7%

-4.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses